Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HELP Study ExtensionTM: An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of DX-2930 for Prevention Against Acute Attacks of Hereditary Angioedema (HAE)

NCT02741596 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT02741596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02741596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HELP Study ExtensionTM: An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of DX-2930 for Prevention Against Acute Attacks of Hereditary Angioedema (HAE)
Lead sponsor
Shire
Phase
Phase 3
Overall status
Completed
Start date
May 26, 2016
Completion date
October 31, 2019
Enrollment
212 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary angioedema (hae)